Plain-language terms

  • Trophectoderm: the outer cell layer of a blastocyst-stage embryo. A small sample of these cells can be taken for DNA testing without using the inner cell mass that becomes the fetus.
  • SNP (single-nucleotide polymorphism): a single-letter DNA difference used as a marker on commercial cattle genotyping chips.
  • Imputation: a statistical step that fills in missing SNP calls by using parental genotypes and a population haplotype map. It can reduce missing and erroneous calls when biopsy DNA is sparse; it does not guarantee a perfect genotype.
  • GEBV (genomic estimated breeding value): a prediction of an animal’s genetic merit for a trait, calculated from SNPs and a reference population of animals with known genotypes and phenotypes. It is a prediction, not a measured carcass or milk record.

Why this matters on a working herd

Embryo transfer (ET) and in vitro production (IVP) already multiply genetics from a few donors across many recipients. A further step is to genotype the embryo itself before transfer—so recipients carry the embryo with the preferred GEBV, sex, or lower chromosomal risk.

That package is preimplantation genomic selection. It is not gene editing. A trophectoderm biopsy and SNP chip read DNA already present in the embryo; editing the genome is a different technology.

For a Wagyu or Akaushi program the practical question is: when does embryo genomics justify biopsy risk, lab fees, freeze delay, and recipient inventory? Published work shows the laboratory workflow can work. It also shows that predictions inherit the reference population behind the evaluation—and that a GEBV does not guarantee pregnancy, calving, or carcass outcome.

What is established in published cattle work

  1. Blastocyst biopsy + whole-genome amplification (WGA) + SNP genotyping can yield usable genotypes from roughly 10–20 trophectoderm cells when DNA quality and call rates are adequate.1–3
  2. Imputation is often used because raw biopsy call rates are typically lower than postnatal hair or blood samples. When parental and population data are available, imputation can fill gaps and reduce genotyping error enough to support ranking; results still depend on call quality and the imputation panel.1,3
  3. Shojaei Saadi et al. (2014) reported that genetic indexes from embryo biopsies and from the corresponding calves after birth were highly correlated after imputation (r = 0.99).1 That is concordance between two genomic predictions (embryo biopsy vs postnatal sample)—not direct validation against measured carcass phenotypes or proof of lifelong performance accuracy.
  4. Japanese Black carcass traits have been evaluated at the blastocyst stage. Fujii et al. (2019) reported high SNP call rates from ~15-cell biopsies, close concordance of GEBVs for carcass weight, ribeye area, and marbling between biopsy and resulting calves, and a 41.9% conception rate after transfer of vitrified GEBV-evaluated blastocysts (13/31). In the same study, 88.5% (184/208) of biopsied samples met the call-rate threshold used for GEBV calculation.2 That is Japanese Black evidence under that study’s evaluation system. It is not validation for U.S. registry evaluations, U.S. reference populations, or Akaushi applicability.
  5. In Gir IVF work, biopsied embryos maintained pregnancy rates similar to non-biopsied controls in that system, while GEBVs correlated usefully with calf genotypes after high-density imputation.3,4
  6. The same SNP data used for GEBVs can also be examined for aneuploidy (extra or missing chromosomes). In a blind retrospective analysis of 1,713 transferred IVP cattle blastocysts, embryos classified as euploid had higher pregnancy and live-birth rates than those classified as aneuploid. The authors estimated that elective euploid transfer would have raised pregnancy and live-birth rates by about 7.5 and 5.8 percentage points relative to that transferred pool.5 Those are retrospective estimates of selection gains, not results from a prospective trial that transferred only euploid embryos by design.

U.S. import pathways for many embryos emphasize disease controls and an intact zona pellucida.6 Biopsy opens the zona. Whether that affects a given shipment or domestic movement is jurisdiction- and pathway-specific—a question for the attending veterinarian and the embryo lab under the rules that apply to that movement, not a universal prohibition on biopsied embryos.4,6

Limits, breed context, and cost framing

  • Reference populations matter. GEBVs track the animals and traits used to train the prediction. Japanese Black carcass equations do not automatically apply to U.S. Fullblood Wagyu, F1 programs, or Akaushi. Dairy milk panels do not answer marbling questions. Sparse or poorly matched reference data usually mean lower prediction usefulness.4,7
  • U.S. Wagyu / Akaushi gap. Large open U.S. Wagyu or Akaushi embryo-biopsy GEBV validation series remain thinner than Holstein, Gir, or Japanese Black pipelines in the sources reviewed here.2–5,8
  • Sample failure. Fujii et al. found 88.5% (184/208) of biopsied samples suitable for GEBV calculation; other programs report wide pre-imputation call-rate ranges.2,3,8 Plan for embryos that cannot be ranked. Reference 8 is a 2025 conference abstract.
  • Sibling variation. Full-sib embryos from one flush can differ in GEBVs.2,3 Morphology alone is a limited ranking tool.
  • Aneuploidy screening looks useful in large IVP datasets,5 but mosaicism detection, embryo stage/grade, and lab protocols make results system-dependent.
  • Cost frame. Direct fees include biopsy, WGA, chip, analysis, and cryopreservation while waiting,4 plus recipient synchronization. Those costs should be weighed against concentrating transfers on higher-GEBV or euploid candidates. This article does not estimate ranch return on investment. Where breed or trait reference data are thin, genotyping postnatal calves to strengthen the reference set may be the clearer next step.

Caveats that stay with the science

Prediction usefulness is lower when the embryo’s ancestry is poorly represented in the reference population. Without careful WGA handling and imputation, embryo rankings can degrade.1,3 A euploid, high-GEBV embryo can still fail to implant; recipient status, embryo stage and grade, and herd conditions remain important outcome drivers.5,9 Concordance of embryo and calf GEBVs is not the same as accuracy against later carcass or maternal phenotypes.